跳至主要内容
临床试验/NCT03761992
NCT03761992Unknown不适用

Measurement of the Effect of Gingko Biloba Extract on Ocular and Nailfold Blood-flow in Normaltension Glaucoma by Ocular Coherence Tomography Angiography and Nailfold Capillaroscopy

Robert Ritch, MD, LLC.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2018年11月19日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
40
试验地点
1
主要终点
Primary Outcome - Measure of Blood Vessel by Optical Cohrence Tomography Angiography (OCTA)

研究概览

简要总结

The purpose of this study is to evaluate the effect of Ginkgo biloba extract (GBE) on the number of blood vessels in the back of the eye as well as the amount of blood flow at the nailfold(where the fingernail meets the skin) of the 4th finger in the hand.This finger, along with the 5th finger, has the most transparent skin, which makes imaging a little easier. GBE is an over-the-counter pill, made from a natural powder taken from the Gingko (Maidenhair) tree, that is widely used. A technique called Optical Coherence Tomography Angiography (OCTA),will be used to measure the small blood vessels at the back of the eye, the macula (the area of sharpest vision), and the optic disc (the point at which the nerve fibers from the retina enter to form the optic nerve, which transmits visual impulses to the brain).

详细描述

GBE has been reported to improve blood flow to the brain, eye, and extremeties(hands, feet,etc.). .As with most supplements, GBE is neither regulated nor FDA approved.

A technique called Optical Coherence Tomography Angiography (OCTA),will be used to measure the small blood vessels at the back of the eye, the macula (the area of sharpest vision), and the optic disc (the point at which the nerve fibers from the retina enter to form the optic nerve, which transmits visual impulses to the brain). This technique uses a camera, capable of imaging the smallest vessels, so that their density (number) can be calculated by a computer. This is being done to determine if there is disease causing increasing loss of these vessels. The imaging is done by a widely used camera which does not contact the eye. It simply uses visible light to measure the amount of blood vessels present in a determined area in the back of the eye. Blood flow at the 4th finger nailfold (nailfold capillaroscopy; NFC) is a standard technique, especially in rheumatology, performed by using a commercially available light microscope which glides over the base of the fingernail and can image the tiny capillaries in the nailfold. These images are recorded as videos from which the blood flow can be analyzed by freely available software for the purpose of quantitative measurements (amount of blood flow and blood flow velocity).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

盲法说明

Neither the patient nor the investigator will know which treatment that the patient is receiving.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Male or female of any race, at least 18 years of age
  • Has provided verbal and written informed consent.
  • Able and willing to follow instructions, including participation in all study assessments and visits.
  • Eyes with NTG will be enrolled.
  • Glaucoma severity will be graded using the WHO (World Health Organization)staging system.
  • NTG diagnosis will be based on the following:
  • Glaucomatous optic disc on slit-lamp biomicroscopy defined as cup-to-disc ratio greater than 0.7, inter-eye asymmetry in cup-to-disc ration greater than 0.2 or neuroretinal rim notching, focal thinning, disc hemorrhage or vertical elongation of optic disc.
  • Glaucomatous visual field defects on at least three reliable visual field examinations as measured by a glaucoma hemifield test (GHT) result outside normal limits and/or the appearance of at least three consecutive test points on the pattern deviation plot with p<1% and at least one at p<0.05%, not including points on the edge of the field.
  • NTG will be defined as those subjects with a history of untreated peak IOP ≤21 mmHg.
  • Both eyes will be enrolled

排除标准

  • Best-corrected visual acuity less than 20/40
  • Age younger than 18 years or older than 85 years
  • Refractive error greater than +3.00 diopters (D) or less than -7.00 diopters (D)
  • Previous intraocular surgery except for uncomplicated cataract extraction with posterior chamber intraocular lens implantation
  • Any other diseases that may cause visual field loss or optic disc abnormalities
  • Inability to perform reliably on automated visual field testing.
  • Subjects taking any GBE product will be washed out for 2 weeks prior to enrollment.
  • Diabetes.
  • Seizure disorder.
  • Taking any drugs that may interact with GBE (as listed).

结局指标

主要结局

Primary Outcome - Measure of Blood Vessel by Optical Cohrence Tomography Angiography (OCTA)

时间窗: 4 weeks

The investigators plan to evaluate the density of the small blood vessels at the back of the eye. This will be measured by a OCTA. A camera capable of imaging the smallest vessels so that their density (number) can be calculated by a computer, the purpose being to determine if there is disease causing progressive loss of these vessels.

次要结局

  • Secondary Outcome - Measure of Blood Flow and Velocity by Nailfold Capillaroscopy (NFC)(4 weeks)

研究者

发起方
Robert Ritch, MD, LLC.
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Measurement of the Effect of Gingko Biloba Extract... | 临床试验